FRI-330 - Determination of the optimum timing of the start of nucleoside analogue by FIB-4 index for hepatitis B patients from the viewpoint of suppressing hepatocarcinogenesis

Saved in:
Bibliographic Details
Published inJournal of hepatology Vol. 68; p. S511
Main Authors Hige, S., Ozeki, I., Tatsumi, R., Yamaguchi, M., Kimura, M., Arakawa, T., Nakajima, T., Kuwata, Y., Ohmura, T., Toyota, J., Karino, Y.
Format Journal Article
LanguageEnglish
Published Elsevier B.V 01.04.2018
Online AccessGet full text

Cover

More Information
ISSN:0168-8278
1600-0641
DOI:10.1016/S0168-8278(18)31270-4